Using Optical Genome Mapping to Identify Genetic Variants in Patients
Official title: Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort
Run by Bionano Genomics · NCT05295277 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new method called Optical Genome Mapping to see if it can find genetic changes in patients with developmental and intellectual disabilities better and faster than current genetic tests.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Bionano Genomics Industry-sponsored |
| Locations | 8 sites (Atlanta, Georgia and 7 other locations) |
| Trial ID | NCT05295277 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with previously identified genomic aberrations from standard genetic tests or those with negative results but still suspected of having genetic conditions.
✕Probably not a fit
Patients with specific genetic variants or those who opted out of research at the testing laboratory may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to validate Optical Genome Mapping (OGM) as a method for detecting genomic structural variants in patients with various developmental and intellectual disabilities. The study will compare the results of OGM with those obtained from standard genetic testing methods, such as chromosomal microarray analysis and next-generation sequencing. By analyzing ultra-long DNA molecules, OGM can identify a wide range of genetic alterations, including deletions and duplications, and provide results within a few days. The study involves a multi-site approach, gathering data from several institutions to assess the effectiveness of this new technology.
Why it matters
Potential benefit: If successful, this study could provide a faster and more comprehensive method for identifying genetic variants that contribute to developmental and intellectual disabilities.
How similar studies have gone: Other studies have shown promising results for Optical Genome Mapping, indicating its potential effectiveness compared to standard testing methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Individual with a genomic aberration identified by CMA, karyotyping, Southern blot analysis, PCR, FISH, and/or NGS or other standard of care (SOC) genetic testing technology whose clinical test results are available to compare with results from OGM. 2. Patients with prior negative SOC genetic testing results whose results are available to compare with results from OGM. Exclusion Criteria: 1. Any individual who opted-out of research at the testing laboratory. 2. An individual whose genetic test contains the following variants: pathogenic sequence variants, abnormalities involving acrocentric p-arms and centromeres, below 20% for mosaicism, and tetraploidy.
Where it's running
-
Greenwood Genetic Center
Greenwood, South Carolina, United States Recruiting -
Lineagen (A Bionano Genomics Company)
Salt Lake City, Utah, United States Recruiting -
Praxis Genomics
Atlanta, Georgia, United States Active not recruiting -
Augusta University Research Institute
Augusta, Georgia, United States Active not recruiting -
University of Iowa Hospitals & Clinics, Molecular Pathology
Iowa City, Iowa, United States Active not recruiting -
Columbia University Irving Medical Center
New York, New York, United States Active not recruiting
Show 2 more locations
-
DNA Microarray CGH Laboratory, Department of Pathology, University of Rochester Medical Center
W. Henrietta, New York, United States Active not recruiting -
Medical College of Wisconsin
Milwaukee, Wisconsin, United States Active not recruiting
Study contacts
- Principal investigator: Alka Chaubey, PhD, FACMG — Bionano Genomics
- Study coordinator: Alex Hastie, PhD
- Email: ahastie@bionanogenomics.com
- Phone: 267-315-0914
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inclusive physical activity program for adults with intellectual disabilities
This study is testing a new fitness program for adults with intellectual disabilities to see if it helps them be more active and feel better over 16 weeks.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Smart Inhaler Use at Home for Adolescents with IDD and Asthma
This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.
-
Using preferred communication tools to reduce challenging behavior
This project will test whether using a person's favored communication tool (for example a touch talker or picture cards) helps keep behavior improvements and prevents relapse in people with intellectual or developmental disabilities who have little or no verbal speech.
-
Theta Burst Stimulation for Emotion Regulation in Autism With Minimal Verbal Ability or Intellectual Disability
This trial tests whether intermittent theta burst stimulation to the left prefrontal cortex can help improve emotion regulation in people with autism who are minimally verbal or have an intellectual disability.
-
Examining the link between motor skills and sensory processing in children aged 4 to 11
This study looks at how motor skills and sensory processing are connected in children aged 4 to 11, including those with conditions like Autism, ADHD, and Developmental Coordination Disorder.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.